{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:20:03Z","timestamp":1785795603219,"version":"3.56.0"},"reference-count":200,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.clcc.2022.12.002","type":"journal-article","created":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T20:12:30Z","timestamp":1672344750000},"page":"24-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["GI Symptoms in Pancreatic Cancer"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3640-7235","authenticated-orcid":false,"given":"Victor T.","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Sandifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengming","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2022.12.002_bib0001","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic cancer: a review","volume":"326","author":"Park","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.clcc.2022.12.002_bib0002","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clcc.2022.12.002_bib0003","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1200\/JOP.2014.000976","article-title":"Correlation of clinical stage and performance status with quality of life in patients seen in a pancreas multidisciplinary clinic","volume":"11","author":"Moningi","year":"2015","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.clcc.2022.12.002_bib0004","doi-asserted-by":"crossref","first-page":"E45","DOI":"10.1188\/08.ONF.E45-E52","article-title":"Symptom concerns and quality of life in hepatobiliary cancers","volume":"35","author":"Sun","year":"2008","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.clcc.2022.12.002_bib0005","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1017\/S1478951517000608","article-title":"Association between pancreatic cancer patients' perception of their care coordination and patient-reported and survival outcomes","volume":"16","author":"Beesley","year":"2018","journal-title":"Palliat Support Care"},{"key":"10.1016\/j.clcc.2022.12.002_bib0006","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12913-022-07625-y","article-title":"A qualitative investigation of the supportive care experiences of people living with pancreatic and oesophagogastric cancer","volume":"22","author":"Khan","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.clcc.2022.12.002_bib0007","doi-asserted-by":"crossref","first-page":"243","DOI":"10.14694\/EdBook_AM.2012.32.15","article-title":"A myriad of symptoms: new approaches to optimizing palliative care of patients with advanced pancreatic cancer","author":"Wiebe","year":"2012","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.clcc.2022.12.002_bib0008","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11864-020-00801-4","article-title":"Symptom Management in Pancreatic Cancer","volume":"22","author":"Lee","year":"2021","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0009","doi-asserted-by":"crossref","unstructured":"Moffat GT, Epstein AS, O'Reilly EM. Pancreatic cancer-A disease in need: optimizing and integrating supportive care. Cancer. 2019;125:3927-35. doi: 10.1002\/cncr.32423.","DOI":"10.1002\/cncr.32423"},{"key":"10.1016\/j.clcc.2022.12.002_bib0010","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1016\/j.lpm.2019.02.032","article-title":"Pancreatic cancer: best supportive care","volume":"48","author":"V\u00e9die","year":"2019","journal-title":"Presse Med"},{"key":"10.1016\/j.clcc.2022.12.002_bib0011","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jpainsymman.2019.08.024","article-title":"The role of a symptom assessment tool in shaping patient-physician communication in palliative care","volume":"59","author":"Brooks","year":"2020","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clcc.2022.12.002_bib0012","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jpainsymman.2016.10.370","article-title":"The edmonton symptom assessment system 25 years later: past, present, and future developments","volume":"53","author":"Hui","year":"2017","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clcc.2022.12.002_bib0013","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1002\/cncr.24920","article-title":"Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI)","volume":"116","author":"Wang","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2022.12.002_bib0014","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/1097-0142(20000901)89:5<1162::AID-CNCR26>3.0.CO;2-Y","article-title":"The memorial symptom assessment scale short form (MSAS-SF)","volume":"89","author":"Chang","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2022.12.002_bib0015","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0959-8049(99)00047-7","article-title":"Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life","volume":"35","author":"Fitzsimmons","year":"1999","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clcc.2022.12.002_bib0016","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1200\/JCO.2002.07.093","article-title":"Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy-hepatobiliary questionnaire","volume":"20","author":"Heffernan","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0017","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.hpb.2019.09.002","article-title":"Patient-reported outcome measures (PROMs) in pancreatic cancer: a systematic review","volume":"22","author":"Maharaj","year":"2020","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.clcc.2022.12.002_bib0018","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/MPA.0000000000001507","article-title":"Landscape of health-related quality of life in patients with early-stage pancreatic cancer receiving adjuvant or neoadjuvant chemotherapy: a systematic literature review","volume":"49","author":"Macarulla","year":"2020","journal-title":"Pancreas"},{"key":"10.1016\/j.clcc.2022.12.002_bib0019","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmjspcare-2020-002538","article-title":"Gastrointestinal malignancies and supportive care trials: a snapshot of the last two decades","volume":"12","author":"Kouzy","year":"2022","journal-title":"BMJ Support Palliat Care"},{"key":"10.1016\/j.clcc.2022.12.002_bib0020","doi-asserted-by":"crossref","first-page":"E36","DOI":"10.1188\/18.ONF.E36-E52","article-title":"Symptom clusters in patients with pancreatic cancer undergoing surgical resection: part I","volume":"45","author":"Burrell","year":"2018","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.clcc.2022.12.002_bib0021","doi-asserted-by":"crossref","first-page":"E53","DOI":"10.1188\/18.ONF.E53-E66","article-title":"Symptom clusters in patients with pancreatic cancer undergoing surgical resection: part II","volume":"45","author":"Burrell","year":"2018","journal-title":"Oncol Nurs Forum"},{"issue":"2","key":"10.1016\/j.clcc.2022.12.002_bib0022","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1245\/s10434-009-0774-0","article-title":"Malignant ascites symptom cluster in patients referred for paracentesis","volume":"17","author":"Husain","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0023","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jpainsymman.2017.10.004","article-title":"Changes in the occurrence, severity, and distress of symptoms in patients with gastrointestinal cancers receiving chemotherapy","volume":"55","author":"Tantoy","year":"2018","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clcc.2022.12.002_bib0024","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jpainsymman.2019.04.035","article-title":"Symptom clusters in patients with gastrointestinal cancers using different dimensions of the symptom experience","volume":"58","author":"Han","year":"2019","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clcc.2022.12.002_bib0025","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S1542-3565(04)00171-5","article-title":"Signs and symptoms of pancreatic cancer: a population-based case-control study in the San Francisco Bay area","volume":"2","author":"Holly","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0026","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.2217\/fon-2020-0749","article-title":"Chart review of diagnostic methods, baseline characteristics and symptoms for European patients with pancreatic cancer","volume":"17","author":"Carrato","year":"2021","journal-title":"Future Oncol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0027","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2019.3348","article-title":"Population-level symptom assessment following pancreaticoduodenectomy for adenocarcinoma","volume":"154","author":"Tung","year":"2019","journal-title":"JAMA Surg"},{"key":"10.1016\/j.clcc.2022.12.002_bib0028","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/jso.24499","article-title":"Impact of pancreatectomy on long-term patient-reported symptoms and quality of life in recurrence-free survivors of pancreatic and periampullary neoplasms","volume":"115","author":"Cloyd","year":"2017","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0029","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/MPA.0000000000001629","article-title":"Symptom burden of nonresected pancreatic adenocarcinoma: an analysis of 10,753 patient-reported outcome assessments","volume":"49","author":"Mavros","year":"2020","journal-title":"Pancreas"},{"key":"10.1016\/j.clcc.2022.12.002_bib0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/NCC.0000000000000463","article-title":"The symptom experience of patients with advanced pancreatic cancer: an integrative review","volume":"41","author":"Tang","year":"2018","journal-title":"Cancer Nurs"},{"key":"10.1016\/j.clcc.2022.12.002_bib0031","first-page":"1443","article-title":"The FOCCUS study: a prospective evaluation of the frequency, severity and treatable causes of gastrointestinal symptoms during and after chemotherapy","volume":"29","author":"Andreyev","year":"2021","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clcc.2022.12.002_bib0032","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12904-020-00610-4","article-title":"Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice","volume":"19","author":"Laquente","year":"2020","journal-title":"BMC Palliat Care"},{"key":"10.1016\/j.clcc.2022.12.002_bib0033","article-title":"Index symptoms and prognosis awareness of patients with pancreatic cancer: a multi-site palliative care collaborative","author":"Johnson","year":"2021","journal-title":"J Palliat Care"},{"key":"10.1016\/j.clcc.2022.12.002_bib0034","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.hpb.2019.04.016","article-title":"Symptom trajectories and predictors of severe symptoms in pancreatic adenocarcinoma at the end-of-life: a population based analysis of 2,538 patients","volume":"21","author":"Hammad","year":"2019","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.clcc.2022.12.002_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101441","article-title":"Critical changes in hypothalamic gene networks in response to pancreatic cancer as found by single-cell RNA sequencing","volume":"58","author":"Huisman","year":"2022","journal-title":"Mol Metab"},{"key":"10.1016\/j.clcc.2022.12.002_bib0036","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.trecan.2022.01.004","article-title":"Emerging signaling mediators in the anorexia-cachexia syndrome of cancer","volume":"8","author":"Talbert","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.clcc.2022.12.002_bib0037","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/s41467-021-22361-3","article-title":"Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia","volume":"12","author":"Olson","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.clcc.2022.12.002_bib0038","first-page":"e12838","article-title":"Symptom experiences in patients with advanced pancreatic cancer as reported during healthcare encounters","volume":"27","author":"Tang","year":"2018","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.clcc.2022.12.002_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejon.2020.101838","article-title":"Psychosocial consequences of a reduced ability to eat for patients with cancer and their informal caregivers: a qualitative study","volume":"49","author":"Lize","year":"2020","journal-title":"Eur J Oncol Nurs"},{"key":"10.1016\/j.clcc.2022.12.002_bib0040","first-page":"e13595","article-title":"Patients with cancer experience high impact of emotional consequences of reduced ability to eat: a cross sectional survey study","volume":"31","author":"Lize","year":"2022","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.clcc.2022.12.002_bib0041","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s11136-019-02135-7","article-title":"Comprehensive validation of the functional assessment of anorexia\/cachexia therapy (FAACT) anorexia\/cachexia subscale (A\/CS) in lung cancer patients with involuntary weight loss","volume":"28","author":"Gelhorn","year":"2019","journal-title":"Qual Life Res"},{"key":"10.1016\/j.clcc.2022.12.002_bib0042","doi-asserted-by":"crossref","first-page":"e982","DOI":"10.1200\/OP.20.00685","article-title":"Diet and nutrition advice after a solid tumor diagnosis","volume":"17","author":"Mullee","year":"2021","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.clcc.2022.12.002_bib0043","first-page":"6343","article-title":"Experiences of patients with cancer with information and support for psychosocial consequences of reduced ability to eat: a qualitative interview study","volume":"29","author":"Lize","year":"2021","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clcc.2022.12.002_bib0044","unstructured":"NCCN Guidelines Version 1.2022 Palliative Care https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/palliative.pdf. Accessed: August 28, 2022."},{"key":"10.1016\/j.clcc.2022.12.002_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100092","article-title":"Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines\u2606","volume":"6","author":"Arends","year":"2021","journal-title":"ESMO Open"},{"key":"10.1016\/j.clcc.2022.12.002_bib0046","doi-asserted-by":"crossref","first-page":"50","DOI":"10.21037\/apm.2018.05.08","article-title":"A hunger for hunger: a review of palliative therapies for cancer-associated anorexia","volume":"8","author":"Childs","year":"2019","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.clcc.2022.12.002_bib0047","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1002\/cncr.32406","article-title":"A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in advanced gastrointestinal cancer patients with cancer cachexia","volume":"125","author":"Hamauchi","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2022.12.002_bib0048","doi-asserted-by":"crossref","unstructured":"Sexton M, Garcia JM, Jatoi A, Clark CS, Wallace MS. The management of cancer symptoms and treatment-induced side effects with cannabis or cannabinoids. J Natl Cancer Inst Monogr 2021;2021:86-98. doi: 10.1093\/jncimonographs\/lgab011.","DOI":"10.1093\/jncimonographs\/lgab011"},{"key":"10.1016\/j.clcc.2022.12.002_bib0049","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1089\/jpm.2011.0098","article-title":"Clinical outcomes and contributors to weight loss in a cancer cachexia clinic","volume":"14","author":"Del Fabbro","year":"2011","journal-title":"J Palliat Med"},{"key":"10.1016\/j.clcc.2022.12.002_bib0050","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2036.2006.03238.x","article-title":"Chronic constipation: a survey of the patient perspective","volume":"25","author":"Johanson","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clcc.2022.12.002_bib0051","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00002820-198906000-00012","article-title":"Validity and reliability of the constipation assessment scale","volume":"12","author":"McMillan","year":"1989","journal-title":"Cancer Nurs"},{"key":"10.1016\/j.clcc.2022.12.002_bib0052","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jpainsymman.2014.10.013","article-title":"Modified Edmonton Symptom Assessment System including constipation and sleep: validation in outpatients with cancer","volume":"49","author":"Hannon","year":"2015","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clcc.2022.12.002_bib0053","first-page":"457","article-title":"Assessment of constipation in patients with cancer","volume":"7","author":"Wickham","year":"2016","journal-title":"J Adv Pract Oncol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0054","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0040-1714245","article-title":"Metrics Used to Quantify Fecal Incontinence and Constipation","volume":"34","author":"Hunt","year":"2021","journal-title":"Clin Colon Rectal Surg"},{"key":"10.1016\/j.clcc.2022.12.002_bib0055","first-page":"23","article-title":"MASCC recommendations on the management of constipation in patients with advanced cancer","volume":"28","author":"Davies","year":"2020","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clcc.2022.12.002_bib0056","doi-asserted-by":"crossref","first-page":"iv111","DOI":"10.1093\/annonc\/mdy148","article-title":"Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines","volume":"29","author":"Larkin","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0057","unstructured":"PAL 17. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/palliative.pdf. Accessed: August 28, 2022."},{"key":"10.1016\/j.clcc.2022.12.002_bib0058","unstructured":"PAL-18. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/palliative.pdf. Accessed: August 28, 2022."},{"issue":"4","key":"10.1016\/j.clcc.2022.12.002_bib0059","doi-asserted-by":"crossref","first-page":"iv126","DOI":"10.1093\/annonc\/mdy145","article-title":"Electronic address: clinicalguidelines@esmo.org. Diarrhoea in adult cancer patients: ESMO clinical practice guidelines","volume":"29","author":"Bossi","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0060","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1001\/jamaoncol.2020.1052","article-title":"Olanzapine for the treatment of advanced cancer-related chronic nausea and\/or vomiting: a randomized pilot trial","volume":"6","author":"Navari","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0061","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-029942","article-title":"Methotrimeprazine versus haloperidol in palliative care patients with cancer-related nausea: a randomised, double-blind controlled trial","volume":"9","author":"Hardy","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.clcc.2022.12.002_bib0062","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1186\/s12885-018-4404-8","article-title":"A randomized open-label study of guideline-driven antiemetic therapy versus single agent antiemetic therapy in patients with advanced cancer and nausea not related to anticancer treatment","volume":"18","author":"Hardy","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clcc.2022.12.002_bib0063","first-page":"8097","article-title":"MASCC antiemetics in advanced cancer updated guideline","volume":"29","author":"Davis","year":"2021","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clcc.2022.12.002_bib0064","unstructured":"PAL-15. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/palliative.pdf. Accessed: August 28, 2022."},{"key":"10.1016\/j.clcc.2022.12.002_bib0065","article-title":"Acupuncture as a tool to reduce nausea in terminally ill patients","author":"Br\u00f8ndum","year":"2021","journal-title":"Scand J Caring Sci"},{"key":"10.1016\/j.clcc.2022.12.002_bib0066","first-page":"8089","article-title":"Medical management of malignant bowel obstruction in patients with advanced cancer: 2021 MASCC guideline update","volume":"29","author":"Davis","year":"2021","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clcc.2022.12.002_bib0067","first-page":"4711","article-title":"MASCC multidisciplinary evidence-based recommendations for the management of malignant bowel obstruction in advanced cancer","volume":"30","author":"Madariaga","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clcc.2022.12.002_bib0068","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpainsymman.2016.05.032","article-title":"Somatostatin analogues compared with placebo and other pharmacologic agents in the management of symptoms of inoperable malignant bowel obstruction: a systematic review","volume":"52","author":"Obita","year":"2016","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clcc.2022.12.002_bib0069","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11864-020-0704-8","article-title":"Nausea and vomiting in advanced cancer","volume":"21","author":"Navari","year":"2020","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0070","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/082585970301900203","article-title":"My love is hurting: the meaning spouses attribute to their loved ones' pain during palliative care","volume":"19","author":"Mehta","year":"2003","journal-title":"J Palliat Care"},{"key":"10.1016\/j.clcc.2022.12.002_bib0071","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/0885-3924(88)90028-0","article-title":"Pain syndromes and pharmacologic management of pancreatic cancer pain","volume":"3","author":"Foley","year":"1988","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clcc.2022.12.002_bib0072","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jpain.2016.10.020","article-title":"AAPT diagnostic criteria for chronic cancer pain conditions","volume":"18","author":"Paice","year":"2017","journal-title":"J Pain"},{"key":"10.1016\/j.clcc.2022.12.002_bib0073","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/j.gastro.2008.09.029","article-title":"Pancreatic neuropathy and neuropathic pain\u2013a comprehensive pathomorphological study of 546 cases","volume":"136","author":"Ceyhan","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clcc.2022.12.002_bib0074","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.3390\/cancers13184594","article-title":"Perineural invasion and associated pain transmission in pancreatic cancer","volume":"13","author":"Wang","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clcc.2022.12.002_bib0075","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00006676-200104000-00009","article-title":"Abdominal pain in patients with resectable pancreatic cancer with reference to clinicopathologic findings","volume":"22","author":"Okusaka","year":"2001","journal-title":"Pancreas"},{"key":"10.1016\/j.clcc.2022.12.002_bib0076","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1007\/s11605-017-3513-z","article-title":"Prospective evaluation of associations between cancer-related pain and perineural invasion in patients with resectable pancreatic adenocarcinoma","volume":"21","author":"Carr","year":"2017","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.clcc.2022.12.002_bib0077","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1097\/MPA.0000000000001899","article-title":"Pancreatic pain-knowledge gaps and research opportunities in children and adults: summary of a national institute of diabetes and digestive and kidney diseases workshop","volume":"50","author":"Uc","year":"2021","journal-title":"Pancreas"},{"key":"10.1016\/j.clcc.2022.12.002_bib0078","series-title":"Oxford Textbook of Palliative Medicine","first-page":"345","article-title":"Chronic cancer pain syndromes","author":"Cherny","year":"2021"},{"key":"10.1016\/j.clcc.2022.12.002_bib0079","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1200\/JCO.1995.13.3.748","article-title":"Pain and depression in patients with newly diagnosed pancreas cancer","volume":"13","author":"Kelsen","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0080","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.dld.2017.06.012","article-title":"A preoperative score to predict early death after pancreatic cancer resection","volume":"49","author":"Balzano","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clcc.2022.12.002_bib0081","first-page":"706","article-title":"Pooling of prognostic studies in cancer of the pancreatic head and periampullary region: the Triple-P study","volume":"166","author":"Terwee","year":"2000","journal-title":"Triple-P Study Group Eur J Surg"},{"key":"10.1016\/j.clcc.2022.12.002_bib0082","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1002\/cncr.33532","article-title":"Cancer pain self-management in the context of a national opioid epidemic: experiences of patients with advanced cancer using opioids","volume":"127","author":"Azizoddin","year":"2021","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.clcc.2022.12.002_bib0083","first-page":"S66","article-title":"An interdisciplinary approach to metastatic pancreatic cancer and comorbid opioid use disorder treatment within a VA health care system","volume":"38","author":"Ruskin","year":"2021","journal-title":"Fed Pract"},{"key":"10.1016\/j.clcc.2022.12.002_bib0084","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jpainsymman.2020.06.039","article-title":"Palliative care's role managing cancer pain during the opioid crisis: a qualitative study of patients, caregivers, and clinicians","volume":"60","author":"Brooks","year":"2020","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clcc.2022.12.002_bib0085","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.39968","article-title":"Expert panel consensus on management of advanced cancer-related pain in individuals with opioid use disorder","volume":"4","author":"Merlin","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clcc.2022.12.002_bib0086","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2022.2191","article-title":"Consensus-based guidance on opioid management in individuals with advanced cancer-related pain and opioid misuse or use disorder","author":"Fitzgerald Jones","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0087","doi-asserted-by":"crossref","first-page":"e995","DOI":"10.1097\/PR9.0000000000000995","article-title":"Nonopioid drug combinations for cancer pain: a systematic review","volume":"7","author":"Sohi","year":"2021","journal-title":"Pain Rep"},{"key":"10.1016\/j.clcc.2022.12.002_bib0088","first-page":"3009","article-title":"Patient experience and quality of life during neoadjuvant therapy for pancreatic cancer: a systematic review and study protocol","volume":"29","author":"Cloyd","year":"2021","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clcc.2022.12.002_bib0089","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1055\/s-0035-1553742","article-title":"EFSUMB guidelines on interventional ultrasound (INVUS), Part V - EUS-guided therapeutic interventions (short version)","volume":"37","author":"Fusaroli","year":"2016","journal-title":"Ultraschall Med"},{"key":"10.1016\/j.clcc.2022.12.002_bib0090","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1136\/gutjnl-2017-314341","article-title":"Consensus guidelines on the optimal management in interventional EUS procedures: results from the Asian EUS group RAND\/UCLA expert panel","volume":"67","author":"Teoh","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.clcc.2022.12.002_bib0091","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4103\/eus.eus_97_17","article-title":"Practice guidelines for endoscopic ultrasound-guided celiac plexus neurolysis","volume":"6","author":"Wyse","year":"2017","journal-title":"Endosc Ultrasound"},{"key":"10.1016\/j.clcc.2022.12.002_bib0092","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/941726","article-title":"Splanchnicectomy for pancreatic cancer pain","volume":"2014","author":"Masuda","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.clcc.2022.12.002_bib0093","first-page":"E583","article-title":"Pancreatic cancer related pain: review of pathophysiology and intrathecal drug delivery systems for pain management","volume":"24","author":"Carvajal","year":"2021","journal-title":"Pain Physician"},{"key":"10.1016\/j.clcc.2022.12.002_bib0094","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1080\/0284186X.2017.1400692","article-title":"Pain relief after a short course of palliative radiotherapy in pancreatic cancer, the Academic Medical Center (AMC) experience","volume":"57","author":"Ebrahimi","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0095","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.3390\/curroncol29040214","article-title":"Pain relief after stereotactic radiotherapy of pancreatic adenocarcinoma: an updated systematic review","volume":"29","author":"Buwenge","year":"2022","journal-title":"Curr Oncol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0096","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1200\/JCO.2013.54.4825","article-title":"Psychological and behavioral approaches to cancer pain management","volume":"32","author":"Syrjala","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0097","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/SPC.0000000000000046","article-title":"The biopsychosocial model in cancer pain","volume":"8","author":"Novy","year":"2014","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.clcc.2022.12.002_bib0098","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1017\/S1478951520000115","article-title":"Enhancing meaning in the face of advanced cancer and pain: qualitative evaluation of a meaning-centered psychosocial pain management intervention","volume":"18","author":"Winger","year":"2020","journal-title":"Palliat Support Care"},{"key":"10.1016\/j.clcc.2022.12.002_bib0099","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1200\/JCO.2004.06.140","article-title":"Randomized clinical trial of the effectiveness of a self-care intervention to improve cancer pain management","volume":"22","author":"Miaskowski","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1188\/12.ONF.39-49","article-title":"A randomized, clinical trial of education or motivational-interviewing-based coaching compared to usual care to improve cancer pain management","volume":"39","author":"Thomas","year":"2012","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.clcc.2022.12.002_bib0101","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1200\/JCO.2011.37.0437","article-title":"Meta-analysis of psychosocial interventions to reduce pain in patients with cancer","volume":"30","author":"Sheinfeld Gorin","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0102","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1177\/02692163211004216","article-title":"Caregiver-guided pain coping skills training for patients with advanced cancer: results from a randomized clinical trial","volume":"35","author":"Porter","year":"2021","journal-title":"Palliat Med"},{"key":"10.1016\/j.clcc.2022.12.002_bib0103","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1089\/jpm.2020.0405","article-title":"Acupuncture and Derived therapies for pain in palliative cancer management: systematic review and meta-analysis based on single-arm and controlled trials","volume":"24","author":"Dai","year":"2021","journal-title":"J Palliat Med"},{"key":"10.1016\/j.clcc.2022.12.002_bib0104","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/bmjspcare-2020-002638","article-title":"Acupuncture for palliative cancer pain management: systematic review","volume":"11","author":"Yang","year":"2021","journal-title":"BMJ Support Palliat Care"},{"key":"10.1016\/j.clcc.2022.12.002_bib0105","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/PPO.0000000000000399","article-title":"Integrative medicine therapies for pain management in cancer patients","volume":"25","author":"Deng","year":"2019","journal-title":"Cancer J"},{"issue":"1","key":"10.1016\/j.clcc.2022.12.002_bib0106","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1097\/j.pain.0000000000001929","article-title":"Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials","volume":"162","author":"Fisher","year":"2021","journal-title":"Pain"},{"key":"10.1016\/j.clcc.2022.12.002_bib0107","doi-asserted-by":"crossref","first-page":"e971","DOI":"10.1002\/onco.13796","article-title":"Pancreas cancer-associated pain management","volume":"26","author":"Coveler","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.clcc.2022.12.002_bib0108","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.21873\/anticanres.14133","article-title":"Pathogenesis and treatment of pancreatic cancer related pain","volume":"40","author":"Lohse","year":"2020","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clcc.2022.12.002_bib0109","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.pan.2018.04.008","article-title":"Pain in pancreatic ductal adenocarcinoma: a multidisciplinary, International guideline for optimized management","volume":"18","author":"Drewes","year":"2018","journal-title":"Pancreatology"},{"key":"10.1016\/j.clcc.2022.12.002_bib0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11864-019-0691-9","article-title":"Chemotherapy-induced sarcopenia","volume":"21","author":"Bozzetti","year":"2020","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0111","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1200\/JOP.2017.025221","article-title":"Prevalence and survival impact of pretreatment cancer-associated weight loss: a tool for guiding early palliative care","volume":"14","author":"Gannavarapu","year":"2018","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.clcc.2022.12.002_bib0112","doi-asserted-by":"crossref","first-page":"79884","DOI":"10.18632\/oncotarget.20168","article-title":"Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study","volume":"8","author":"Muscaritoli","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.clcc.2022.12.002_bib0113","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s11605-008-0505-z","article-title":"Cachexia worsens prognosis in patients with resectable pancreatic cancer","volume":"12","author":"Bachmann","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.clcc.2022.12.002_bib0114","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1200\/JCO.2014.56.1894","article-title":"Diagnostic criteria for the classification of cancer-associated weight loss","volume":"33","author":"Martin","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0115","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/jcsm.12756","article-title":"Diagnostic criteria for cancer cachexia: reduced food intake and inflammation predict weight loss and survival in an international, multi-cohort analysis","volume":"12","author":"Martin","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clcc.2022.12.002_bib0116","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s11605-017-3618-4","article-title":"Anthropometric changes in patients with pancreatic cancer undergoing preoperative therapy and pancreatoduodenectomy","volume":"22","author":"Cloyd","year":"2018","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.clcc.2022.12.002_bib0117","first-page":"322","article-title":"Assessing nutritional status in cancer: role of the patient-generated subjective global assessment","volume":"20","author":"Jager-Wittenaar","year":"2017","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.clcc.2022.12.002_bib0118","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1017\/S000711451100571X","article-title":"Validation of the Malnutrition Universal Screening Tool (MUST) in cancer","volume":"108","author":"Bol\u00e9o-Tom\u00e9","year":"2012","journal-title":"Br J Nutr"},{"key":"10.1016\/j.clcc.2022.12.002_bib0119","doi-asserted-by":"crossref","first-page":"M366","DOI":"10.1093\/gerona\/56.6.M366","article-title":"Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNA-SF)","volume":"56","author":"Rubenstein","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.clcc.2022.12.002_bib0120","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0261-5614(02)00214-5","article-title":"Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials","volume":"22","author":"Kondrup","year":"2003","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clcc.2022.12.002_bib0121","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.603936","article-title":"Nutritional risk screening in cancer patients: the first step toward better clinical outcome","volume":"8","author":"Reber","year":"2021","journal-title":"Front Nutr"},{"key":"10.1016\/j.clcc.2022.12.002_bib0122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clnu.2018.08.002","article-title":"GLIM criteria for the diagnosis of malnutrition - a consensus report from the global clinical nutrition community","volume":"38","author":"Cederholm","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clcc.2022.12.002_bib0123","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1634\/theoncologist.2018-0266","article-title":"Pancreas cancer-associated weight loss","volume":"24","author":"Hendifar","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.clcc.2022.12.002_bib0124","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.clnu.2021.02.005","article-title":"ESPEN practical guideline: clinical nutrition in cancer","volume":"40","author":"Muscaritoli","year":"2021","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clcc.2022.12.002_bib0125","first-page":"5673","article-title":"Oral nutrition interventions in patients undergoing gastrointestinal surgery for cancer: a systematic literature review","volume":"28","author":"Reece","year":"2020","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clcc.2022.12.002_bib0126","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jnci\/djr556","article-title":"Oral nutritional interventions in malnourished patients with cancer: a systematic review and meta-analysis","volume":"104","author":"Baldwin","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clcc.2022.12.002_bib0127","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1093\/annonc\/mdy114","article-title":"Systematic review and meta-analysis of the evidence for oral nutritional intervention on nutritional and clinical outcomes during chemo(radio)therapy: current evidence and guidance for design of future trials","volume":"29","author":"de van der Schueren","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0128","article-title":"Clinical and economic value of oral nutrition supplements in patients with cancer: a position paper from the survivorship care and nutritional support working group of alliance against cancer","author":"Caccialanza","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clcc.2022.12.002_bib0129","first-page":"2983","article-title":"Multinational Association of Supportive Care in Cancer (MASCC) expert opinion\/guidance on the use of clinically assisted nutrition in patients with advanced cancer","volume":"30","author":"Alderman","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clcc.2022.12.002_bib0130","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jpainsymman.2010.02.015","volume":"40","author":"Hopkinson","year":"2010","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clcc.2022.12.002_bib0131","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12937-020-00657-2","article-title":"The effects of a family-centered psychosocial-based nutrition intervention in patients with advanced cancer: the PiCNIC2 pilot randomised controlled trial","volume":"20","author":"Molassiotis","year":"2021","journal-title":"Nutr J"},{"key":"10.1016\/j.clcc.2022.12.002_bib0132","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jpainsymman.2017.01.010","article-title":"Management of cancer cachexia and guidelines implementation in a comprehensive cancer center: a physician-led cancer nutrition program adapted to the practices of a country","volume":"54","author":"Senesse","year":"2017","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clcc.2022.12.002_bib0133","doi-asserted-by":"crossref","DOI":"10.1177\/1758835919880084","article-title":"From guidelines to clinical practice: a roadmap for oncologists for nutrition therapy for cancer patients","volume":"11","author":"Muscaritoli","year":"2019","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0134","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000442873","article-title":"Nutrition in pancreatic cancer: a review","volume":"2","author":"G\u00e4rtner","year":"2016","journal-title":"Gastrointest Tumors"},{"key":"10.1016\/j.clcc.2022.12.002_bib0135","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.3390\/cancers14092212","article-title":"Nutritional interventions in pancreatic cancer: a systematic review","volume":"14","author":"Emanuel","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clcc.2022.12.002_bib0136","first-page":"360","article-title":"Pancreas adenocarcinoma: ascites, clinical manifestations, and management implications","volume":"15","author":"Hicks","year":"2016","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.clcc.2022.12.002_bib0137","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1089\/jpm.2017.0616","article-title":"Therapeutic procedures for malignant ascites in a palliative care outpatient clinic","volume":"21","author":"Korpi","year":"2018","journal-title":"J Palliat Med"},{"key":"10.1016\/j.clcc.2022.12.002_bib0138","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jpainsymman.2018.03.016","article-title":"Validation of the edmonton symptom assessment system: ascites modification","volume":"55","author":"Mori","year":"2018","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clcc.2022.12.002_bib0139","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1245\/s10434-007-9370-3","article-title":"The ability of existing questionnaires to measure symptom change after paracentesis for symptomatic ascites","volume":"14","author":"Easson","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0140","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s13539-014-0142-1","article-title":"Psychosocial impact of cancer cachexia","volume":"5","author":"Hopkinson","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clcc.2022.12.002_bib0141","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/jcsm.12910","article-title":"Addressing unmet needs for people with cancer cachexia: recommendations from a multistakeholder workshop","volume":"13","author":"Garcia","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clcc.2022.12.002_bib0142","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/0269216315588743","article-title":"A systematic review and thematic synthesis of quality of life in the informal carers of cancer patients with cachexia","volume":"30","author":"Wheelwright","year":"2016","journal-title":"Palliat Med"},{"key":"10.1016\/j.clcc.2022.12.002_bib0143","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jpainsymman.2012.06.020","article-title":"Psychosocial effects of cancer cachexia: a systematic literature search and qualitative analysis","volume":"46","author":"Oberholzer","year":"2013","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clcc.2022.12.002_bib0144","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1017\/S0029665118000186","article-title":"Barriers to cancer nutrition therapy: excess catabolism of muscle and adipose tissues induced by tumour products and chemotherapy","volume":"77","author":"Schiessel","year":"2018","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.clcc.2022.12.002_bib0145","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/s41416-021-01301-4","article-title":"Pancreatic cancer cachexia: three dimensions of a complex syndrome","volume":"124","author":"Kordes","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clcc.2022.12.002_bib0146","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0147","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/0884533616680354","article-title":"Differentiating sarcopenia and cachexia among patients with cancer","volume":"32","author":"Peterson","year":"2017","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clcc.2022.12.002_bib0148","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jpainsymman.2016.09.010","article-title":"Development of the EORTC QLQ-CAX24, a questionnaire for cancer patients with cachexia","volume":"53","author":"Wheelwright","year":"2017","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clcc.2022.12.002_bib0149","unstructured":"PAL 13. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/palliative.pdf. Accessed: August 28, 2022."},{"key":"10.1016\/j.clcc.2022.12.002_bib0150","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1200\/JCO.20.00611","article-title":"Management of Cancer Cachexia: ASCO guideline","volume":"38","author":"Roeland","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0151","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/1747-0080.12631","article-title":"Clinical oncology society of Australia: position statement on cancer-related malnutrition and sarcopenia","volume":"77","author":"Kiss","year":"2020","journal-title":"Nutr Diet"},{"key":"10.1016\/j.clcc.2022.12.002_bib0152","doi-asserted-by":"crossref","first-page":"9385","DOI":"10.1002\/cam4.3556","article-title":"Cachexia, dietetic consultation, and survival in patients with pancreatic and periampullary cancer: a multicenter cohort study","volume":"9","author":"Latenstein","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.clcc.2022.12.002_bib0153","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/jcsm.12490","article-title":"Defining barriers to implementation of nutritional advice in patients with cachexia","volume":"11","author":"Nasrah","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clcc.2022.12.002_bib0154","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/jcsm.12525","article-title":"Nutrition interventions to treat low muscle mass in cancer","volume":"11","author":"Prado","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clcc.2022.12.002_bib0155","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.critrevonc.2019.08.006","article-title":"Integration of palliative, supportive, and nutritional care to alleviate eating-related distress among advanced cancer patients with cachexia and their family members","volume":"143","author":"Amano","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0156","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4103\/apjon.apjon-219","article-title":"The psychosocial components of multimodal interventions offered to people with cancer cachexia: a scoping review","volume":"8","author":"Hopkinson","year":"2021","journal-title":"Asia Pac J Oncol Nurs"},{"key":"10.1016\/j.clcc.2022.12.002_bib0157","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/bmjspcare-2017-001440","article-title":"Cancer cachexia: rationale for the MENAC (Multimodal-Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial","volume":"8","author":"Solheim","year":"2018","journal-title":"BMJ Support Palliat Care"},{"key":"10.1016\/j.clcc.2022.12.002_bib0158","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00256-020-03576-9","article-title":"Diagnosing sarcopenia at the point of imaging care: analysis of clinical, functional, and opportunistic CT metrics","volume":"50","author":"Yao","year":"2021","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0159","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijsu.2018.09.014","article-title":"Sarcopenia and sarcopenic obesity are significantly associated with poorer overall survival in patients with pancreatic cancer: systematic review and meta-analysis","volume":"59","author":"Mintziras","year":"2018","journal-title":"Int J Surg"},{"key":"10.1016\/j.clcc.2022.12.002_bib0160","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.pan.2021.10.004","article-title":"A review of physical activity in pancreatic ductal adenocarcinoma: epidemiology, intervention, animal models, and clinical trials","volume":"22","author":"Hsueh","year":"2022","journal-title":"Pancreatology"},{"key":"10.1016\/j.clcc.2022.12.002_bib0161","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/cncr.34154","article-title":"A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in patients with cancer cachexia and low body mass index","volume":"128","author":"Naito","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2022.12.002_bib0162","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.clnesp.2018.02.006","article-title":"Should omega-3 fatty acids be used for adjuvant treatment of cancer cachexia?","volume":"25","author":"Lavriv","year":"2018","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.clcc.2022.12.002_bib0163","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/jcsm.12861","article-title":"Cannabinoid interventions for improving cachexia outcomes in cancer: a systematic review and meta-analysis","volume":"13","author":"Simon","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clcc.2022.12.002_bib0164","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4103\/apjon.apjon-2130","article-title":"Review of the effects and safety of traditional Chinese medicine in the treatment of cancer cachexia","volume":"8","author":"Xu","year":"2021","journal-title":"Asia Pac J Oncol Nurs"},{"key":"10.1016\/j.clcc.2022.12.002_bib0165","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF01318117","article-title":"Pancreatic carcinoma is associated with delayed gastric emptying","volume":"31","author":"Barkin","year":"1986","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clcc.2022.12.002_bib0166","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gtc.2014.11.001","article-title":"Gastroparesis: definitions and diagnosis","volume":"44","author":"Pasricha","year":"2015","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.clcc.2022.12.002_bib0167","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10620-008-0354-3","article-title":"Diagnostic and therapeutic approach to pancreatic cancer-associated gastroparesis: literature review and our experience","volume":"54","author":"Leung","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clcc.2022.12.002_bib0168","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2147\/DDDT.S125743","article-title":"Mirtazapine for symptom control in refractory gastroparesis","volume":"11","author":"Malamood","year":"2017","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.clcc.2022.12.002_bib0169","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4103\/IJPC.IJPC_17_17","article-title":"Effect of mirtazapine on gastric emptying in patients with cancer-associated anorexia","volume":"23","author":"Kumar","year":"2017","journal-title":"Indian J Palliat Care"},{"key":"10.1016\/j.clcc.2022.12.002_bib0170","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1177\/02692163221081331","article-title":"Symptom burden and lived experiences of patients, caregivers and healthcare professionals on the management of malignant bowel obstruction: a qualitative systematic review","volume":"36","author":"Baddeley","year":"2022","journal-title":"Palliat Med"},{"key":"10.1016\/j.clcc.2022.12.002_bib0171","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/0825859719861935","article-title":"Management of cancer-associated intestinal obstruction in the final year of life","volume":"35","author":"Merchant","year":"2020","journal-title":"J Palliat Care"},{"key":"10.1016\/j.clcc.2022.12.002_bib0172","doi-asserted-by":"crossref","first-page":"e186","DOI":"10.1200\/OP.20.00035","article-title":"Illness understanding, prognostic awareness, and end-of-life care in patients with gi cancer and malignant bowel obstruction with drainage percutaneous endoscopic gastrostomy","volume":"17","author":"Goldberg","year":"2021","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.clcc.2022.12.002_bib0173","first-page":"367","article-title":"Gaps in patient-physician communication at the time of malignant bowel obstruction from recurrent gynecologic cancer: a qualitative study","volume":"30","author":"Hoppenot","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clcc.2022.12.002_bib0174","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1089\/jpm.2013.0397","article-title":"Palliative gastrostomy in the setting of voluminous ascites","volume":"17","author":"O'Connor","year":"2014","journal-title":"J Palliat Med"},{"key":"10.1016\/j.clcc.2022.12.002_bib0175","doi-asserted-by":"crossref","unstructured":"Siddappa PK, Hawa F, Prokop LJ, et\u00a0al. Endoscopic pancreatic duct stenting for pain palliation in selected pancreatic cancer patients: a systematic review and meta-analysis. Gastroenterol Rep (Oxf) 2021;9:105-14. doi: 10.1093\/gastro\/goab001.","DOI":"10.1093\/gastro\/goab001"},{"key":"10.1016\/j.clcc.2022.12.002_bib0176","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/gut.35.4.467","article-title":"Symptom relief and quality of life after stenting for malignant bile duct obstruction","volume":"35","author":"Ballinger","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.clcc.2022.12.002_bib0177","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/MCG.0b013e318272440e","article-title":"Effect of endoscopic stenting of malignant bile duct obstruction on quality of life","volume":"47","author":"Barkay","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0178","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/MEG.0000000000001957","article-title":"Patient-reported experience measure in pancreatobiliary endoscopy: a systematic review to highlight areas for improvement","volume":"33","author":"Apadula","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0179","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/jso.25451","article-title":"Malignant bowel obstruction","volume":"120","author":"Krouse","year":"2019","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0180","doi-asserted-by":"crossref","first-page":"28","DOI":"10.21037\/tgh.2019.04.03","article-title":"Palliative therapy in pancreatic cancer-palliative surgery","volume":"4","author":"Perinel","year":"2019","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0181","unstructured":"PAL 20. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/palliative.pdf. Accessed: August 28, 2022."},{"key":"10.1016\/j.clcc.2022.12.002_bib0182","first-page":"1835","article-title":"Pancreatic cancer and supportive care\u2013pancreatic exocrine insufficiency negatively impacts on quality of life","volume":"21","author":"Gooden","year":"2013","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clcc.2022.12.002_bib0183","doi-asserted-by":"crossref","first-page":"e13066","DOI":"10.1111\/ijcp.13066","article-title":"Introduction and practical approach to exocrine pancreatic insufficiency for the practicing clinician","volume":"72","author":"Othman","year":"2018","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.clcc.2022.12.002_bib0184","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MPA.0000000000000473","article-title":"Pancreatic exocrine insufficiency in patients with pancreatic or periampullary cancer: a systematic review","volume":"45","author":"Tseng","year":"2016","journal-title":"Pancreas"},{"key":"10.1016\/j.clcc.2022.12.002_bib0185","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.dld.2015.06.015","article-title":"Pancreatic exocrine insufficiency in pancreatic cancer: a review of the literature","volume":"47","author":"Bartel","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clcc.2022.12.002_bib0186","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.cgh.2018.01.027","article-title":"Diagnostic performance of measurement of fecal elastase-1 in detection of exocrine pancreatic insufficiency: systematic review and meta-analysis","volume":"16","author":"Vanga","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clcc.2022.12.002_bib0187","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100386","article-title":"Expert opinion on management of pancreatic exocrine insufficiency in pancreatic cancer","volume":"7","author":"Roeyen","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.clcc.2022.12.002_bib0188","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1097\/MPA.0000000000001906","article-title":"Pancreatic enzyme replacement therapy for patients diagnosed with pancreaticobiliary cancer: validation of an algorithm for dose escalation and management","volume":"50","author":"Carnie","year":"2021","journal-title":"Pancreas"},{"key":"10.1016\/j.clcc.2022.12.002_bib0189","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1200\/OP.21.00466","article-title":"Financial burden of drugs prescribed for cancer-associated symptoms","volume":"18","author":"Gupta","year":"2022","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.clcc.2022.12.002_bib0190","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/MPA.0000000000001330","article-title":"Frequency of appropriate use of pancreatic enzyme replacement therapy and symptomatic response in pancreatic cancer patients","volume":"48","author":"Barkin","year":"2019","journal-title":"Pancreas"},{"key":"10.1016\/j.clcc.2022.12.002_bib0191","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/MPA.0000000000002049","article-title":"The impact of pancreatic enzyme replacement therapy on patients with advanced pancreatic adenocarcinoma: a systematic review and narrative synthesis","volume":"51","author":"Landers","year":"2022","journal-title":"Pancreas"},{"key":"10.1016\/j.clcc.2022.12.002_bib0192","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/jhbp.1085","article-title":"Synopsis of a clinical practice guideline for pancreatic ductal adenocarcinoma with peritoneal dissemination in Japan; Japan Peritoneal malignancy study group","volume":"29","author":"Satoi","year":"2022","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.clcc.2022.12.002_bib0193","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.soc.2021.02.004","article-title":"A palliative approach to management of peritoneal carcinomatosis and malignant ascites","volume":"30","author":"Bleicher","year":"2021","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.clcc.2022.12.002_bib0194","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.pan.2017.01.008","article-title":"Anxiety, depression and quality of life in people with pancreatic cancer and their carers","volume":"17","author":"Janda","year":"2017","journal-title":"Pancreatology"},{"key":"10.1016\/j.clcc.2022.12.002_bib0195","first-page":"3691","article-title":"Caring experiences of family caregivers of patients with pancreatic cancer: an integrative literature review","volume":"30","author":"Kim","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clcc.2022.12.002_bib0196","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0304-3959(02)00448-7","article-title":"The self-efficacy of family caregivers for helping cancer patients manage pain at end-of-life","volume":"103","author":"Keefe","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.clcc.2022.12.002_bib0197","article-title":"Coping in patients with pancreatic cancer: a scoping review and narrative synthesis","author":"Ristau","year":"2021","journal-title":"BMJ Support Palliat Care"},{"key":"10.1016\/j.clcc.2022.12.002_bib0198","first-page":"e13280","article-title":"Diet and nutrition information on nine national cancer organisation websites: a critical review","volume":"29","author":"Barrett","year":"2020","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.clcc.2022.12.002_bib0199","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/s43018-020-00146-9","article-title":"Future directions in preclinical and translational cancer neuroscience research","volume":"1","author":"Demir","year":"2021","journal-title":"Nat Cancer"},{"key":"10.1016\/j.clcc.2022.12.002_bib0200","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1016\/S1470-2045(21)00596-9","article-title":"Therapeutic avenues for cancer neuroscience: translational frontiers and clinical opportunities","volume":"23","author":"Shi","year":"2022","journal-title":"Lancet Oncol"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002822001359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002822001359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:09:52Z","timestamp":1761520192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002822001359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":200,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1533002822001359"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2022.12.002","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GI Symptoms in Pancreatic Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2022.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}